# OncXerna Therapeutics, Ltd. — Form D

OncXerna Therapeutics, Ltd. of Waltham, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-03-04. The offering totals $100.0M, of which $30.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2022-03-04
- Form: D
- Accession: 0001567619-22-006334
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $100.0M
- Amount sold: $30.0M
- Remaining: $70.0M
- Investors: 4
- Date of first sale: 2022-02-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-435862

## Issuer

- Name: OncXerna Therapeutics, Ltd.
- CIK: 0001914838
- Entity type: Corporation
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2018
- Address: 300 Fifth Avenue, Suite 6040, Waltham, MA, 02451
- Phone: (781) 907-7810

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Chrystiyna Bedrij | Director | Waltham, MA |
| Laura Benjamin | Director | Boston, MA |
| Peter Bisgaard | Director | South San Francisco, CA |
| Benjamin Chen | Director | Waltham, MA |
| Vincent Cheung | Director | Waltham, MA |

## More

- [CIK 1914838 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1914838&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001567619-22-006334.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.